Range Low Price High Price Comment
30 days $4.61 $7.24 Tuesday, 30th Apr 2024 AFMD stock ended at $5.35. This is 2.55% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 7.65% from a day low at $5.10 to a day high of $5.49.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Dec 08, 2021 $65.80 $69.00 $64.00 $68.30 152 292
Dec 07, 2021 $61.50 $66.00 $61.50 $64.50 300 719
Dec 06, 2021 $59.90 $61.35 $57.10 $61.00 191 076
Dec 03, 2021 $66.60 $66.70 $59.40 $60.70 336 721
Dec 02, 2021 $67.50 $68.00 $64.60 $65.80 193 904
Dec 01, 2021 $68.50 $70.20 $66.90 $67.50 212 216
Nov 30, 2021 $68.70 $69.60 $65.90 $68.20 287 365
Nov 29, 2021 $70.80 $71.30 $68.70 $69.20 159 563
Nov 26, 2021 $69.70 $71.30 $67.80 $69.70 101 637
Nov 24, 2021 $66.90 $70.85 $65.60 $70.70 260 721
Nov 23, 2021 $69.55 $69.70 $65.30 $68.10 402 965
Nov 22, 2021 $71.40 $73.50 $63.60 $70.50 1 108 529
Nov 19, 2021 $67.80 $68.50 $65.43 $67.30 206 746
Nov 18, 2021 $66.90 $68.20 $65.45 $68.10 187 874
Nov 17, 2021 $62.20 $70.00 $61.20 $67.30 553 426
Nov 16, 2021 $60.40 $61.80 $59.41 $61.20 180 954
Nov 15, 2021 $59.20 $60.40 $58.46 $60.40 233 074
Nov 12, 2021 $57.90 $59.10 $56.40 $59.10 199 438
Nov 11, 2021 $57.40 $61.25 $57.30 $58.70 213 022
Nov 10, 2021 $56.50 $58.00 $55.00 $56.50 293 160
Nov 09, 2021 $63.50 $64.10 $61.80 $62.30 240 406
Nov 08, 2021 $68.00 $68.10 $63.00 $63.40 169 772
Nov 05, 2021 $65.10 $68.60 $64.10 $67.60 153 221
Nov 04, 2021 $68.60 $69.70 $58.00 $64.60 433 172
Nov 03, 2021 $70.60 $72.50 $69.95 $70.20 343 795
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT